0001752724-21-047856.txt : 20210309 0001752724-21-047856.hdr.sgml : 20210309 20210309163204 ACCESSION NUMBER: 0001752724-21-047856 CONFORMED SUBMISSION TYPE: N-CEN PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20201231 FILED AS OF DATE: 20210309 DATE AS OF CHANGE: 20210309 EFFECTIVENESS DATE: 20210309 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Mirae Asset Discovery Funds CENTRAL INDEX KEY: 0001489215 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 0430 FILING VALUES: FORM TYPE: N-CEN SEC ACT: 1940 Act SEC FILE NUMBER: 811-22406 FILM NUMBER: 21726291 BUSINESS ADDRESS: STREET 1: 625 MADISON AVENUE STREET 2: 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-205-8300 MAIL ADDRESS: STREET 1: 625 MADISON AVENUE STREET 2: 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 0001489215 S000065276 Mirae Asset Emerging Markets Great Consumer VIT Fund C000211317 Class I Shares N-CEN 1 primary_doc.xml X0303 N-CEN LIVE 0001489215 XXXXXXXX 811-22406 true false false N-1A S000065276 true Mirae Asset Discovery Funds 811-22406 0001489215 549300UD1B8SO7KOZC53 625 Madison Avenue 3rd Floor New York 10022 US-NY US 212-205-8300 Mirae Asset Global Investments (USA) LLC 625 Madison Avenue 3rd Floor New York 10022 888-335-3417 Investment manager for Mirae Asset Discovery Funds Citi Fund Services Ohio, Inc. 4400 Easton Commons Suite 200 Columbus 43219 614-470-8471 Administrator and Fund Accounting Agent for Mirae Asset Discovery Funds FIS Investor Services, LLC 4249 Easton Way Suite 400 Columbus 43219 614-337-6684 Transfer Agent for Mirae Asset Discovery Funds Citibank, N.A. 111 Wall Street New York 10005 646-248-6738 Custodian for Mirae Asset Discovery Funds N N N-1A 3 Y Laurence Smith N/A N Keith M. Schappert N/A N Joon Hyuk Heo N/A Y Enrique R. Arzac N/A N Thomas N. Calabria 002780599 625 Madison Avenue 3rd Floor New York 10022 XXXXXX N N N N N N N Funds Distributor, LLC 8-20518 000007174 N/A Y N Cohen & Company, Ltd. 925 N/A N N N N N N N Mirae Asset Emerging Markets Great Consumer VIT Fund S000065276 5493006C1BO3JIVWGO60 N 1 0 0 N/A N N Y N N/A N/A N/A Rule 17e-1 (17 CFR 270.17e-1) Y Y Y N Mirae Asset Global Investments (USA) LLC 801-69439 000147548 549300UD1B8SO7KOZC53 N Mirae Asset Global Investments (Hong Kong) Ltd. 801-71088 000152807 213800TUUUQUT8GHZ555 Y HK N FIS Investor Services LLC 084-06522 N/A N N N Bloomberg L.P. 549300B56MD0ZC402L06 N ICE Data Services 5493000NQ9LYLDBCTL34 N Virtu Financial, Inc. 5493001OPW2K42CH3884 N PricingDirect Inc. 549300WIC0TOJ7N7GD54 N Y Citibank, N.A. E57ODZWZ7FF32TWEFA76 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) Citibank, N.A. E57ODZWZ7FF32TWEFA76 N N Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) N N Citi Fund Services Ohio, Inc. 549300OX9HIV34JOX333 N N N Mirae Asset Securities (Hong Kong) Ltd. N/A 000152807 213800TUUUQUT8GHZ555 HK 438.90 HSBC 008-41562 000019585 CYYGQCGNHMHPSMRL3R97 395.54 MORGAN STANLEY 008-15869 000008209 9R7GPTSO7KV3UQJZQ078 386.80 CLSA LTD. 008-69166 000165533 213800M2DXATWY7JMS07 247.92 MIRAE SECURITIES N/A 000152807 213800TUUUQUT8GHZ555 HK 438.90 CITIGROUP 008-08177 000007059 MBNUM2BPBDO7JBLYG310 767.38 GOLDMAN SACHS & CO. LLC 008-00129 000000361 FOR8UP27PHTHYVLBNG30 301.00 JP MORGAN CHASE 008-35008 000000079 ZBUT11V806EZRVTWT807 482.17 DAIWA CAPITAL MARKETS AMERICA INC. 008-12242 000001576 M67H5PRC0NQKM73ZAS82 216.18 CHINA MERCHANTS SECURITIES HK N/A N/A 549300VCT4IH7HC2NQ22 HK 361.02 UBS WARBURG 008-22651 000007654 T6FIZBDPKLYJKFCRVK44 654.48 5769.89 GOLDMAN SACHS & CO. LLC 008-00129 000000361 FOR8UP27PHTHYVLBNG30 125.00 CITIGROUP 008-08177 000007059 MBNUM2BPBDO7JBLYG310 494108.52 MORGAN STANLEY 008-15869 000008209 9R7GPTSO7KV3UQJZQ078 287.48 494521.00 Y 2768767.90 Uncommitted 15000000.00000000 N N N N false false true false false false INTERNAL CONTROL RPT 2 Mirae_N-CEN_Letter.txt MIRAE N-CEN LETTER REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Shareholders and Board of Trustees of Mirae Asset Discovery Funds In planning and performing our audit of the financial statements of Mirae Asset Discovery Funds comprising Emerging Markets Great Consumer VIT Fund (the 'Fund') as of and for the year ended December 31, 2020, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), we considered the Fund's internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Fund's internal control over financial reporting. Accordingly, we express no such opinion. The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A fund's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles (GAAP). A fund's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the fund; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that receipts and expenditures of the fund are being made only in accordance with authorizations of management and trustees of the fund; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a fund's assets that could have a material effect on the financial statements. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Fund's annual or interim financial statements will not be prevented or detected on a timely basis. Our consideration of the Fund's internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be material weaknesses under standards established by the PCAOB. However, we noted no deficiencies in the Fund's internal control over financial reporting and its operation, including controls over safeguarding securities, that we consider to be a material weakness as defined above as of December 31, 2020. This report is intended solely for the information and use of management and the Board of Trustees of the Fund and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties. COHEN & COMPANY, LTD. Cleveland, Ohio February 25, 2021